BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 24579331)

  • 1. [Screening for breast cancer: worries about its effectiveness].
    Autier P
    Rev Prat; 2013 Dec; 63(10):1369-77. PubMed ID: 24579331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer screening in women aged 50-74 years: is there room for improvement?
    Morère JF; Pivot X; Viguier J; Blay JY; Calazel-Benque A; Coscas Y; Roussel C; Eisinger F
    Eur J Cancer Prev; 2011 Jan; 20 Suppl 1():S8-S12. PubMed ID: 21245683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
    Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
    J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are prognostic factors more favorable for breast cancer detected by organized screening than by opportunistic screening or clinical diagnosis? A study in Loire-Atlantique (France).
    Vanier A; Leux C; Allioux C; Billon-Delacour S; Lombrail P; Molinié F
    Cancer Epidemiol; 2013 Oct; 37(5):683-7. PubMed ID: 23880147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimates of overdiagnosis of invasive breast cancer associated with screening mammography.
    Morrell S; Barratt A; Irwig L; Howard K; Biesheuvel C; Armstrong B
    Cancer Causes Control; 2010 Feb; 21(2):275-82. PubMed ID: 19894130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in aggregate cancer incidence rates in relation to screening and possible overdiagnosis: a word of caution.
    Duffy SW; Michalopoulos D; Sebuødegård S; Hofvind S
    J Med Screen; 2014 Mar; 21(1):24-9. PubMed ID: 24446330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Organized or individual breast cancer screening: what motivates women?].
    Kalecinski J; Régnier-Denois V; Ouédraogo S; Dabakuyo-Yonli TS; Dumas A; Arveux P; Chauvin F
    Sante Publique; 2015; 27(2):213-20. PubMed ID: 26414035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Organized breast cancer screening].
    Rouëssé J; Sancho-Garnier H;
    Bull Acad Natl Med; 2014 Feb; 198(2):369-86. PubMed ID: 26263710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experience in the implementation of screening program for early detection of breast cancer in the Khanty-Mansi Autonomous Region-Yugra].
    Zakharova NA
    Vopr Onkol; 2013; 59(3):382-5. PubMed ID: 23909042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difficulties in implementing an organized screening program for breast cancer in Brazil with emphasis on diagnostic methods.
    Silva TB; Mauad EC; Carvalho AL; Jacobs LA; Shulman LN
    Rural Remote Health; 2013; 13(2):2321. PubMed ID: 23597169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
    Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First report of introducing population-based breast cancer screening in Poland: experience of the 3-million population region of Lower Silesia.
    Matkowski R; Szynglarewicz B
    Cancer Epidemiol; 2011 Dec; 35(6):e111-5. PubMed ID: 21840281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-based study of breast cancer screening in Côte d'Or (France): clinical implications and factors affecting screening round adequacy.
    Ouedraogo S; Dabakuyo TS; Gentil J; Poillot ML; Dancourt V; Arveux P
    Eur J Cancer Prev; 2011 Nov; 20(6):462-74. PubMed ID: 22025137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer screening update.
    Tria Tirona M
    Am Fam Physician; 2013 Feb; 87(4):274-8. PubMed ID: 23418799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding barriers to organized breast cancer screening in France: women's perceptions, attitudes, and knowledge.
    Ferrat E; Le Breton J; Djassibel M; Veerabudun K; Brixi Z; Attali C; Renard V
    Fam Pract; 2013 Aug; 30(4):445-51. PubMed ID: 23478254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-specific interval breast cancers in New South Wales and meta-analysis of studies of women aged 40-49 years.
    Taylor R; Page A; Bampton D; Estoesta J; Rickard M
    J Med Screen; 2004; 11(4):199-206. PubMed ID: 15563775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [French screening program of breast cancer. Results from 5 districts (1989-1994)].
    Séradour B; Allemand H; Schaffer P
    Bull Cancer; 1997 Aug; 84(8):822-8. PubMed ID: 9339188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of an organized, nationwide breast cancer screening programme on non-organized mammography activities.
    Boncz I; Sebestyén A; Pintér I; Battyány I; Ember I
    J Med Screen; 2008; 15(1):14-7. PubMed ID: 18416949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.